https://www.pallashealth.co/glp-1/telehealth-rules Dated, sourced changes to U.S. state telehealth rules for GLP-1 prescribing — video-visit requirements, medical-board citations, and Medicaid GLP-1 coverage. Maintained by Pallas Health; not legal advice. en-us CC BY 4.0 — Pallas Health (https://www.pallashealth.co/glp-1/telehealth-rules) Mon, 27 Jul 2026 12:00:00 GMT https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-ca-pa-sc https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-ca-pa-sc Mon, 27 Jul 2026 12:00:00 GMT California, South Carolina, and Pennsylvania Medicaid programs eliminated coverage of GLP-1s for weight-loss indications effective January 1, 2026 (Medi-Cal removed Wegovy®, Zepbound®, and Saxenda® for members 21 and older; type 2 diabetes coverage continues in all three, and Medi-Cal keeps narrow exceptions such as Wegovy® for cardiovascular risk reduction). With New Hampshire, logged July 25, all four eliminations reported by KFF are now reflected in the tracker. Source: Medi-Cal Rx provider bulletins (October and December 2025) and KFF Medicaid GLP-1 coverage research; surfaced by our automated source check (PR #45). California Pennsylvania South Carolina https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-ri https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-ri Mon, 27 Jul 2026 12:00:00 GMT Rhode Island's FY2027 budget, signed June 12, 2026, ends Medicaid coverage of GLP-1s for weight-loss indications effective October 1, 2026; type 2 diabetes coverage is unaffected. Our note previously described the change as proposed. Source: Rhode Island Current reporting on the enacted FY27 budget (June 12, 2026); surfaced by our automated source check (PR #45). Rhode Island https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-al-co-oh-vt https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-27-al-co-oh-vt Mon, 27 Jul 2026 12:00:00 GMT Correction — statute and rule citations updated on four state pages: Vermont now cites 18 V.S.A. § 9361(b) (previously a nonexistent § 3053a), Ohio cites Ohio Rev. Code § 4743.09 and OAC 4731-37-01 (previously the controlled-substances chapter 4731-11), Colorado cites C.R.S. § 12-240-107 (previously § 12-240-138, the professional-entities section), and Alabama cites Ala. Code §§ 34-24-701 through 34-24-707 (previously the repealed Admin. Code ch. 540-X-15). Regulatory substance is unchanged in all four. Source: State statute and administrative-code databases; surfaced by our automated source check (PR #45). Alabama Colorado Ohio Vermont https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-nh https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-nh Sat, 25 Jul 2026 12:00:00 GMT New Hampshire Medicaid eliminated coverage of GLP-1 medications prescribed solely for weight loss, effective January 1, 2026; coverage continues for type 2 diabetes and certain other chronic conditions with prior authorization. New Hampshire's tracker entry has been updated accordingly. Source: NH Healthy Families member notice (October 2025) and KFF Medicaid GLP-1 coverage research; surfaced by our automated source check (PR #38). New Hampshire https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-ms https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-ms Sat, 25 Jul 2026 12:00:00 GMT Correction — Mississippi Medicaid lists Wegovy® and Saxenda® as preferred anti-obesity agents for weight management (manual prior authorization required); our note previously understated weight-management coverage. Source: Mississippi Division of Medicaid Universal PDL (January 2026) and anti-obesity agent PA criteria; surfaced by our automated source check (PR #38). Mississippi https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-id https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-25-id Sat, 25 Jul 2026 12:00:00 GMT Correction — Idaho renamed its telehealth statute; Idaho Code §54-5701 and following is now the Idaho Virtual Care Access Act (formerly the Telehealth Access Act). Section numbers and substance are unchanged. Source: Idaho Legislature, Title 54, Chapter 57; surfaced by our automated source check (PR #38). Idaho https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-24-ar-dc-ks-nd-sd https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-07-24-ar-dc-ks-nd-sd Fri, 24 Jul 2026 12:00:00 GMT Arkansas, Washington D.C., North Dakota, and South Dakota moved to video-visit-required; Kansas moved to async-eligible. The video-required list now stands at 8 jurisdictions (7 states plus Washington, D.C.). Source: Confirmed with our clinical network's licensing and routing team, 2026-07-24. Arkansas District of Columbia Kansas North Dakota South Dakota https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-05-29-ks-ms-nm-ri-wv https://www.pallashealth.co/glp-1/telehealth-rules#change-2026-05-29-ks-ms-nm-ri-wv Fri, 29 May 2026 12:00:00 GMT Baseline video-visit-required list at tracker inception: New Mexico, Mississippi, Kansas, West Virginia, and Rhode Island (5 jurisdictions). All other states and D.C. permitted asynchronous establishment of care for non-controlled prescriptions. Source: Confirmed with our clinical network's licensing and routing team. Kansas Mississippi New Mexico Rhode Island West Virginia